Table 9.

Total annual direct and indirect costs estimated with one-way sensitivity and scenario analyses in Germany, Sweden, and the UK

Scenario	Germany (billion euros)		Sweden (billion kronas)		UK (billion pounds)
	Direct costs	Indirect costs	Direct costs	Indirect costs	Direct costs	Indirect costs*
Base-case result	€2.32	€20.76	5.11 kr	19.65 kr	£1.35	£4.32
Change the number of patients by ±25 %	€1.87–2.77	€15.57–25.95	3.75–6.51 kr	14.74–24.56 kr	£0.97–1.74	£3.24–5.40
Change the number of patients seeking medical help by ±25 %	€2.01–2.62	No effect	4.17–6.05 kr	No effect	£1.09–1.62	No effect
Change the annual number of clinician visits by ±25 %	€2.25–2.38	No effect	4.33–5.90 kr	No effect	£1.16–1.55	No effect
Change the percentage of patients receiving drug prescriptions by ±25 %	€2.20–2.43	No effect	5.06–5.16 kr	No effect	£1.32–1.39	No effect
Change the percentage of hospitalized patients by ±25 %	€2.20–2.43	No effect	5.03–5.19 kr	No effect	£1.33–1.38	No effect
Change the percentage of patients with a fracture by ±25 %	€2.04–2.59	No effect	4.82–5.41 kr	No effect	£1.29–1.42	No effect
Change the unit costs of clinician visits by ±25 %	€2.26–2.38	No effect	4.35–5.88 kr	No effect	£1.16–1.55	No effect
Change the costs of drugs by ±25 %	€2.19–2.44	No effect	5.06–5.16 kr	No effect	£1.32–1.39	No effect
Change the unit costs of hospitalization and nocturia-related procedures by ±25 %	€1.93–2.71	No effect	4.70–5.53 kr	No effect	£1.25–1.46	No effect
Include the cost of an ultrasound test as within the diagnostic tests	€2.35	No effect	5.74 kr	No effect	£1.43	No effect
0–2 months in a year of not working productively due to nocturia	No effect	€0–36.85	No effect	0–37.00 kr	N/A	N/A
0–1 month in a year of being absent from work due to nocturia	N/A	N/A	N/A	N/A	No effect	£0–12.15
40–60 % of patients are of working age (20–64 years)	No effect	€17.09–25.63	No effect	16.22–24.33 kr	No effect	£3.37–5.05

1 kr ≈ €0.11, £1 ≈ €1.31

* This only includes indirect costs due to absenteeism